zinsol dt (zinc sulphate dispersible tablets usp
macleods pharmaceuticals limited atlanta arcade church road near leela hotel - zinc sulphate dispersible tablets usp 20 mg - dispersible tablet - each uncoated dispersible tablets contains zinc - mineral supplements: zinc
zinc sulfate tablet, dispersible 20 mg
macleods pharmaceuticals limited, india - zinc sulfate - tablet, dispersible - 20 mg
zinc sulfate
macleods pharmaceuticals limited - zinc sulphate monohydrate - tablet; oral - 20mg
zinc sulfate tablets usp 20mg 20mg oral solid ordinary soluble tablets
macleods pharmaceuticals ltd - zinc sulfate monohydrate - oral solid ordinary soluble tablets - 20mg
macleods hydrocortisone injection
macleods pharmaceuticals sa (pty) ltd - injection - see ingredients - each vial contains hydrocortisone sodium succinate equivalent to hydrocortisone 100,0 mg
ethionamide macleods 250 mg tablets
macleods pharmaceuticals sa (pty) ltd - tablet - each tablet contains ethionamide 250,0 mg ethionamide 250,0 mg
terizidone macleods 250 mg capsules
macleods pharmaceuticals sa (pty) ltd - capsules - see ingredients - each capsule contains : terizidone 250,0 mg
atormac 10 (atorvastatin film coated tablet 10mg)
macleods pharmaceuticals sdn. bhd. - atorvastatin calcium trihydrate -
atormac 40 (atorvastatin film coated tablet 40mg)
macleods pharmaceuticals sdn. bhd. - atorvastatin calcium trihydrate -
risedronate sodium tablet, film coated
macleods pharmaceuticals limited - risedronate sodium (unii: ofg5exg60l) (risedronic acid - unii:km2z91756z) - risedronate sodium 5 mg - risedronate sodium tablets, usp are indicated for the treatment and prevention of osteoporosis in postmenopausal women. in postmenopausal women with osteoporosis, risedronate sodium tablets, usp reduces the incidence of vertebral fractures and a composite endpoint of nonvertebral osteoporosis-related fractures [see clinical studies (14.1, 14.2) ]. risedronate sodium tablets, usp are indicated for treatment to increase bone mass in men with osteoporosis. risedronate sodium tablets, usp are indicated for the treatment and prevention of glucocorticoid-induced osteoporosis in men and women who are either initiating or continuing systemic glucocorticoid treatment (daily dosage of greater than or equal to 7.5 mg of prednisone or equivalent) for chronic diseases. patients treated with glucocorticoids should receive adequate amounts of calcium and vitamin d. risedronate sodium tablets, usp are indicated for treatment of paget's disease of bone in men and women. the optimal duration of use has not been determined. t